Tel Aviv - Delayed Quote ILA

XTL Biopharmaceuticals Ltd. (XTLB.TA)

4.4000
-0.1000
(-2.22%)
At close: May 18 at 3:28:55 PM GMT+3
Advanced Chart
Loading Chart for XTLB.TA
  • Previous Close 4.5000
  • Open 4.4000
  • Bid 4.4000 x 2000000
  • Ask 4.5000 x 379200
  • Day's Range 4.4000 - 4.4000
  • 52 Week Range 4.0000 - 11.2000
  • Volume 968,473
  • Avg. Volume 568,443
  • Market Cap (intraday) 39.662M
  • Beta (5Y Monthly) 1.04
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.

www.xtlbio.com

10

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about XTL Biopharmaceuticals Ltd.

Recent News: XTLB.TA

View More
View More

Performance Overview: XTLB.TA

Trailing total returns as of 5/18/2025, which may include dividends or other distributions. Benchmark is TA-125 (^TA125.TA) .

YTD Return

XTLB.TA
32.31%
TA-125 (^TA125.TA)
11.50%

1-Year Return

XTLB.TA
56.00%
TA-125 (^TA125.TA)
35.50%

3-Year Return

XTLB.TA
31.25%
TA-125 (^TA125.TA)
35.93%

5-Year Return

XTLB.TA
10.20%
TA-125 (^TA125.TA)
92.89%

Compare To: XTLB.TA

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

XTLB.TA
XTL Biopharmaceuticals Ltd.
4.4000
-2.22%
Mkt Cap ILA 39.662M
Industry Biotechnology
CGEN
Compugen Ltd.
1.3900
+1.46%
Mkt Cap 129.983M
Industry Biotechnology

Statistics: XTLB.TA

View More

Valuation Measures

Annual
As of 5/15/2025

  • Market Cap

    39.66M

  • Enterprise Value

    36.10M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    19.77

  • Price/Book (mrq)

    2.05

  • Enterprise Value/Revenue

    22.59

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -227.72%

  • Return on Assets (ttm)

    -24.74%

  • Return on Equity (ttm)

    -26.83%

  • Revenue (ttm)

    451k

  • Net Income Avi to Common (ttm)

    -1.03M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.14M

  • Total Debt/Equity (mrq)

    2.54%

  • Levered Free Cash Flow (ttm)

    740k

View More

Research Analysis: XTLB.TA

View More
View More

Company Insights: XTLB.TA

Research Reports: XTLB.TA

View More
View More

People Also Watch

INCR.TA InterCure Ltd.
566.60
+2.68%
 
BLRX.TA BioLineRx Ltd.
1.9000
0.00%
 
FRSX.TA Foresight Autonomous Holdings Ltd.
7.90
-3.66%
 
CANF.TA Can-Fite BioPharma Ltd.
1.4000
+7.69%
 
ENLV.TA Enlivex Therapeutics Ltd.
356.70
-2.78%
 
BONS.TA Bonus BioGroup Ltd.
22.60
+1.80%
 
ORMP.TA Oramed Pharmaceuticals Inc.
765.60
-2.50%
 
TECT.TA Tectona Ltd
290.30
-0.68%
 
EVGN.TA Evogene Ltd.
458.00
+5.82%
 
KDST.TA Kadimastem Ltd
2,449.00
-3.70%
 
PPBT.TA Purple Biotech Ltd
4.2000
+5.00%
 
NVMI.TA Nova Ltd.
67,400.00
-2.39%
 
TGTR.TA Together Pharma Ltd
412.50
-0.10%
 
OPK.TA OPKO Health, Inc.
471.10
+3.42%
 
KMDA.TA Kamada Ltd.
2,442.00
-0.97%
 
APLP.TA Apollo Power Ltd.
295.00
-1.60%